Company logo

NMTR - 9 Meters Biopharma, Inc.

NASDAQ -> Healthcare -> Biotechnology
Raleigh, United States

NMTR price evolution
NMTR
(in millions $) 31 Mar 2022 31 Dec 2021 30 Sep 2021 30 Jun 2021
Current assets
Cash $37.24 $46.99 $53.61 $64.02
Short term investments $0.07
Net receivables
Inventory
Total current assets $39.09 $49.99 $56.48 $65.78
Long term investments
Property, plant & equipment $0.17 $0.18 $0.2 $0.21
Goodwill & intangible assets
Total noncurrent assets $0.18 $0.19 $0.2 $0.21
Total investments $0.07
Total assets $39.26 $50.17 $56.68 $65.99
Current liabilities
Accounts payable $1.91 $2.43 $1.32 $1.64
Deferred revenue
Short long term debt
Total current liabilities $8.22 $8.46 $7.28 $6.72
Long term debt $0.1 $0.11 $0.13 $0.14
Total noncurrent liabilities $0.1 $0.11 $0.13 $0.14
Total debt $0.1 $0.11 $0.13 $0.14
Total liabilities $8.32 $8.57 $7.41 $6.86
Shareholders' equity
Retained earnings -$180.19 -$168.84 -$159.29 -$145.75
Other shareholder equity $0
Total shareholder equity $30.94 $41.6 $49.27 $59.14
(in millions $) 31 Dec 2021 31 Dec 2020 31 Dec 2019 31 Dec 2018
Current assets
Cash $46.99 $37.85 $4.59 $5.73
Short term investments $0.07 $0.07 $0.07
Net receivables
Inventory
Total current assets $49.99 $38.93 $5.22 $6.41
Long term investments
Property, plant & equipment $0.18 $0.23 $0.07 $0.04
Goodwill & intangible assets
Total noncurrent assets $0.19 $0.23 $0.07 $0.04
Total investments $0.07 $0.07 $0.07
Total assets $50.17 $39.16 $5.3 $6.45
Current liabilities
Accounts payable $2.43 $1.49 $3.89 $3.62
Deferred revenue
Short long term debt $0.01 $3.18 $5.2
Total current liabilities $8.46 $6.85 $14.91 $10.11
Long term debt $0.11 $0.17
Total noncurrent liabilities $0.11 $0.17
Total debt $0.11 $0.18 $3.18 $5.2
Total liabilities $8.57 $7.02 $14.91 $10.11
Shareholders' equity
Retained earnings -$168.84 -$132.06 -$70.56 -$43.52
Other shareholder equity $0
Total shareholder equity $41.6 $32.14 -$9.61 -$3.66
(in millions $) 31 Mar 2022 31 Dec 2021 30 Sep 2021 30 Jun 2021
Revenue
Total revenue
Cost of revenue
Gross Profit
Operating activities
Research & development $8.37 $7.05 $6.05 $5.71
Selling, general & administrative $3 $2.52 $2.39 $2.55
Total operating expenses $11.36 $9.56 $13.54 $8.26
Operating income -$11.36 -$9.56 -$13.54 -$8.26
Income from continuing operations
EBIT -$11.35 -$9.55 -$13.54 -$8.25
Income tax expense
Interest expense $0 $0 $0
Net income
Net income -$11.35 -$9.55 -$13.54 -$8.25
Income (for common shares) -$11.35 -$9.55 -$13.54 -$8.25
(in millions $) 30 Jan 2022 31 Dec 2020 31 Dec 2019 31 Dec 2018
Revenue
Total revenue
Cost of revenue
Gross Profit
Operating activities
Research & development $10.93 $13.72 $7.56
Selling, general & administrative $10.52 $10.57 $10.66
Total operating expenses $53.72 $24.28 $18.22
Operating income -$53.72 -$24.28 -$18.22
Income from continuing operations
EBIT -$57.45 -$25.22 -$18.01
Income tax expense
Interest expense $4.05 $1.83 $6.15
Net income
Net income -$61.5 -$27.05 -$24.16
Income (for common shares) -$61.5 -$27.05 -$24.16
(in millions $) 31 Mar 2022 31 Dec 2021 30 Sep 2021 30 Jun 2021
Net income -$11.35 -$9.55 -$13.54 -$8.25
Operating activities
Depreciation $0 $0 $0 $0
Business acquisitions & disposals -$2.49
Stock-based compensation $0.69 $0.53 $0.53 $0.94
Total cash flows from operations -$9.75 -$7.97 -$8.17 -$7.11
Investing activities
Capital expenditures -$0 -$0 -$0 -$0
Investments $0.07
Total cash flows from investing -$0 -$0 -$2.42 -$0
Financing activities
Dividends paid
Sale and purchase of stock $1.36 $0.43 $35.29
Net borrowings
Total cash flows from financing $1.36 $0.18 $32.64
Effect of exchange rate
Change in cash and equivalents -$9.75 -$6.62 -$10.41 $25.53
(in millions $) 31 Dec 2021 31 Dec 2020 31 Dec 2019 31 Dec 2018
Net income -$36.78 -$61.5 -$27.05 -$24.16
Operating activities
Depreciation $0.01 $0.02 $0.02 $0.02
Business acquisitions & disposals -$2.49 -$3.18
Stock-based compensation $2.41 $4.72 $2.87 $3.81
Total cash flows from operations -$29.48 -$19.41 -$17.97 -$15.17
Investing activities
Capital expenditures -$0.01 -$0 -$0.01 -$0.01
Investments $0.07
Total cash flows from investing -$2.43 -$3.19 -$0.01 -$0.01
Financing activities
Dividends paid
Sale and purchase of stock $44.01 $39.68 $20.74 $17.75
Net borrowings -$0.06 $0.02 -$2.85 $3.02
Total cash flows from financing $41.05 $55.86 $16.84 $20.56
Effect of exchange rate
Change in cash and equivalents $9.14 $33.26 -$1.14 $5.37
Fundamentals
Market cap $58.10M
Enterprise value $20.96M
Shares outstanding 258.24M
Revenue $0.00
EBITDA -$42.69M
EBIT -$42.70M
Net Income -$42.70M
Revenue Q/Q N/A
Revenue Y/Y N/A
P/E ratio -1.36
EV/Sales N/A
EV/EBITDA -0.49
EV/EBIT -0.49
P/S ratio N/A
P/B ratio 1.88
Book/Share 0.12
Cash/Share 0.14
EPS -$0.17
ROA -80.52%
ROE -94.39%
Debt/Equity 0.21
Net debt/EBITDA 0.68
Current ratio 4.75
Quick ratio 4.75